Holdings

Frazier Life Sciences Management, L.P.

As of Sep 30, 2026, Frazier Life Sciences Management, L.P. reported 41 positions worth US$3.51B. Largest: Mirum Pharmaceuticals, Inc., Erasca, Inc. and MBX Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Mirum Pharmaceuticals, Inc.7.68MUS$656Mno changeSep 30, 2026
Erasca, Inc.29.5MUS$432M+4.5MSep 30, 2026
MBX Biosciences, Inc.6.65MUS$390Mno changeSep 30, 2026
Arcutis Biotherapeutics, Inc.9.87MUS$261Mno changeSep 30, 2026
Maze Therapeutics, Inc.5.28MUS$144M+250KSep 30, 2026
Trevi Therapeutics, Inc.9.54MUS$137M−400KSep 30, 2026
Krystal Biotech, Inc.391KUS$130M−89,988Sep 30, 2026
Palvella Therapeutics, Inc.882KUS$122Mno changeSep 30, 2026
Attovia Therapeutics, Inc.7.05MUS$121MnewSep 30, 2026
Braveheart Bio, Inc.5.27MUS$106MnewSep 30, 2026